1. Home
  2. ATAI vs QCRH Comparison

ATAI vs QCRH Comparison

Compare ATAI & QCRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • QCRH
  • Stock Information
  • Founded
  • ATAI 2018
  • QCRH 1993
  • Country
  • ATAI Netherlands
  • QCRH United States
  • Employees
  • ATAI N/A
  • QCRH N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • QCRH Major Banks
  • Sector
  • ATAI Health Care
  • QCRH Finance
  • Exchange
  • ATAI Nasdaq
  • QCRH Nasdaq
  • Market Cap
  • ATAI 1.1B
  • QCRH 1.1B
  • IPO Year
  • ATAI 2021
  • QCRH 1993
  • Fundamental
  • Price
  • ATAI $5.88
  • QCRH $72.50
  • Analyst Decision
  • ATAI Strong Buy
  • QCRH Buy
  • Analyst Count
  • ATAI 5
  • QCRH 4
  • Target Price
  • ATAI $14.00
  • QCRH $90.00
  • AVG Volume (30 Days)
  • ATAI 7.1M
  • QCRH 110.9K
  • Earning Date
  • ATAI 11-14-2025
  • QCRH 10-22-2025
  • Dividend Yield
  • ATAI N/A
  • QCRH 0.32%
  • EPS Growth
  • ATAI N/A
  • QCRH 3.93
  • EPS
  • ATAI N/A
  • QCRH 7.15
  • Revenue
  • ATAI $2,309,000.00
  • QCRH $336,623,000.00
  • Revenue This Year
  • ATAI $736.04
  • QCRH N/A
  • Revenue Next Year
  • ATAI N/A
  • QCRH $14.20
  • P/E Ratio
  • ATAI N/A
  • QCRH $10.38
  • Revenue Growth
  • ATAI 510.85
  • QCRH N/A
  • 52 Week Low
  • ATAI $1.04
  • QCRH $60.83
  • 52 Week High
  • ATAI $6.75
  • QCRH $96.08
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 52.01
  • QCRH 46.58
  • Support Level
  • ATAI $5.50
  • QCRH $72.75
  • Resistance Level
  • ATAI $6.23
  • QCRH $77.85
  • Average True Range (ATR)
  • ATAI 0.46
  • QCRH 2.50
  • MACD
  • ATAI -0.06
  • QCRH 0.36
  • Stochastic Oscillator
  • ATAI 26.71
  • QCRH 51.97

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About QCRH QCR Holdings Inc.

QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.

Share on Social Networks: